An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine
- PMID: 32363145
- PMCID: PMC7195299
- DOI: 10.1016/j.hrcr.2020.03.016
An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine
Keywords: Acquired LQTS; Azithromycin; COVID-19; Chloroquine; Drug toxicity; Flow chart; Hydroxychloroquine; Long QT; Pandemic; Proarrhythmia; Torsades de pointes; Ventricular fibrillation.
Figures
References
-
- Colson P., Rolain J.M., Lagier J.C., Brouqui P., Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 [published online ahead of print March 4, 2020]. Int J Antimicrob Agents. https://doi.org/10.1016/j.ijantimicag.2020.105932 - DOI - PMC - PubMed
-
- Gao J., Tian Z., Breakthrough Yang X. Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14:72–73. - PubMed
-
- Gautret P., Lagier J.C., Parola P. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial [published online ahead of print March 20, 2020]. Int J Antimicrob Agents. https://doi.org/10.1016/j.ijantimicag.2020.105949 - DOI - PMC - PubMed
-
- Dunne M.W., Singh N., Shukla M. A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. J Infect Dis. 2005;191:1582–1588. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
